Showing results (71-80 of 212) with videos related to

Sort By:
Pageof 22
International Journal of Clinical Oncology|October 12, 2012
Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphomaDaruka Mahadevan, Donald W Northfelt, Pavani Chalasani, et al.
Molecular Cancer Therapeutics|December 14, 2002
The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivoCory L Grand, Haiyong Han, Rubén M Muñoz, et al.
The Yale Journal of Biology and Medicine|March 28, 2009
Skeletal metastases in pancreatic cancer: a retrospective study and review of the literatureMitesh J Borad, Hamid Saadati, Arun Lakshmipathy, et al.
Pancreas|November 15, 2016
Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine: An Exploratory Analysis From a Phase 3 StudyVolker Kunzmann, Ramesh K Ramanathan, David Goldstein, et al.
Diagnostics (Basel, Switzerland)|March 11, 2023
Can Imaging Using Radiomics and Fat Fraction Analysis Detect Early Tissue Changes on Historical CT Scans in the Regions of the Pancreas Gland That Subsequently Develop Adenocarcinoma?Ronald Lee Korn, Andre Burkett, Jeff Geschwind, et al.
Anticancer Research|May 17, 2002
Irofulven (6-hydroxymethylacylfulvene, MGI 114)-induced apoptosis in human pancreatic cancer cells is mediated by ERK and JNK kinasesWeixin Wang, Stephen J Waters, John R MacDonald, et al.
Cancer Research Communications|June 25, 2025
Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid TumorsPhilippe A Cassier, Mitesh J Borad, Sunil Sharma, et al.
Molecular Cancer Therapeutics|February 19, 2008
Adrenocortical carcinoma survival rates correlated to genomic copy number variantsElizabeth A Stephan, Tae-Hoon Chung, Clive S Grant, et al.
Molecular Cancer Therapeutics|August 12, 2011
CBP501-calmodulin binding contributes to sensitizing tumor cells to cisplatin and bleomycinNaoki Mine, Sayaka Yamamoto, Naoya Saito, et al.
Future Oncology (London, England)|May 10, 2022
A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory adenosquamous carcinoma of the pancreasNebojsa Skorupan, Mehwish I Ahmad, Seth M Steinberg, et al.
Pageof 22